期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

顺铂对化疗患者听功能的影响:引起细胞凋亡和毛细胞再生及移植的机制与进展 被引量：2

Effect of cisplatin on the auditory function of patients with chemotherapy:mechanism of apoptosis and regeneration and transplantation of hair cells and its progress
下载PDF
导出
摘要 顺铂是临床上常用的抗癌药之一,由于其较强的耳毒性而限制了用量,影响化疗后患者的生活质量。为探索顺铂引起细胞凋亡的机制和毛细胞再生、移植等最新防治方法的研究进展,综述了近年来有关顺铂耳毒性的表现和可能机制及其防治方法。
作者 孙宪昌 程秀臻 刘儒林
机构地区 潍坊医学院生理教研室
出处 《中国临床康复》 CSCD 2004年第29期6448-6450,共3页 Chinese Journal of Clinical Rehabilitation
关键词 顺铂 毛细胞再生 细胞凋亡 化疗患者 听功能 移植 耳毒性 可能机制 探索 限制
分类号 R764 [医药卫生—耳鼻咽喉科] R473.73 [医药卫生—护理学]
  • 相关文献

参考文献35

  • 1[1]Simon T, Hero B, Dupuis W, et al. The incidence of hearing impairment after successful treatment of neuroblastoma. Klin Padiatr 2002; 21 (4): 149 -52
  • 2[2]Laurll G, Andersson A, Engstrom B, et al. Disrtribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig.Cancer Chemother Pharmacol 1995; 36:83 -6
  • 3[3]Oh SH, Yu WS, Song BH, et al. Expression of heat shock protein 72 in rat cochlea with cisplatin-induced acute ototoxicity. Acta Otolaryngol 2000; 120:146 - 50
  • 4李凤玲,范淑敏,张静.顺铂对耳蜗毒性的实验研究[J].张家口医学院学报,2002,19(6):12-15. 被引量：1
  • 5[5]Staecker H, Gabaizadeh R, Federoff H, et al. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 1998; 119(1 ): 7 - 13
  • 6[6]Gabaizadeh R, Staecker H, Liu W, et al. Protection of both auditory hair cells and auditory neurons from cisplatin induced damage. Acta Otolaryngol 1997;117(2): 232- 8
  • 7[7]Hinojosa R, Riggs LC, Strauss M, et al. Temporal bone histopathology of cisplatin ototoxicity. Am J Otol 1995; 16(6): 731 -40
  • 8[8]Sockalingam R, Filippich L, Charles B, et al. Cisplatin-induced ototoxicity and pharmacokinetics: preliminary findings in a dog model. Ann Otol Rhinol Laryngol 2002; 111 (8): 745 -50
  • 9廖英俊,汤浩.抗癌药顺铂耳毒性机制及防治方法的研究进展[J].生理科学进展,2003,34(3):266-269. 被引量：17
  • 10李兰,王重远.顺铂耳毒性实验研究[J].中华耳鼻咽喉科杂志,1990,25(4):205-207. 被引量：8

二级参考文献75

  • 1姜鸿彦,王锦玲,邱建华,刘顺利.一氧化氮合酶在正常豚鼠低位听觉径路及血管纹的分布[J].耳鼻咽喉（头颈外科）,1995,2(2):111-114. 被引量：5
  • 2姜鸿彦,王锦玲,黄维国,邱建华,马宏敏.一氧化氮在豚鼠耳蜗作用的实验研究[J].中华耳鼻咽喉科杂志,1997,32(1):28-31. 被引量：11
  • 3[1]Ruan RS. Possible roles of nitric oxide in the physiology and pathophysiology of the mammalian cochlea. Ann N Y Acad Sci 2002; 962:260
  • 4[2]Hoshijima H, Makimoto K, Noi O, et al. Effects of nitric oxide synthase inhibitor on cochlear blood flow. Hear Res 2002; 171 (1 -2):32- 2
  • 5[3]Fessenden JD, Coling DE, Schacht J. Detection and characterization of nitric oxide synthase in the mammalian cochlea. Brain Res 1994; 668 ( 1 - 2): 9 - 15
  • 6[4]Matsumoto T, Nakane M, Pollock JS, et al. A correlation between soluble brain nitric oxide synthase and NADPH-diaphorase activity is only seen after exposure of the tissue to fixative. Neurosci Lett 199; 155(1): 61 -4
  • 7[5]Gosepath K, Heinrich UR, Ecke U, et al. Possible roles of nitric oxide in the physiology and pathophysiology of the guinea pig cochlea. Eur Arch Otorhinnlaryngol 2000; 257 (8): 418 - 24
  • 8[6]Zdanski CJ, Carrasco V, Johnson K, et al. Inhibition of nitric oxide synthase causes elevation of hearing thresholds. Otolaryngol Head Neck Surg 1998, 119(3): 159 -63
  • 9[7]Watanabe KI, Hess A, Bloch W, et al. Nitric oxide synthase inhibitor suppresses the ototoxic side effect of cisplastin in guinea pigs. Anticancer Drugs 2000; 11(5): 401
  • 10[8]Durante W, Kroll MH, Vanhoutte PM, et al. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Blood 1992; 79 ( 1 ): 110 - 6

共引文献56

同被引文献72

  • 1魏嘉,刘宝瑞,王亚平,钱晓萍.DNA修复基因单核苷酸多态性与铂类药物抵抗研究进展[J].中华肿瘤杂志,2006,28(3):161-163. 被引量：31
  • 2王晶,冯晓辉.顺铂耳毒性的监测及防护[J].医学临床研究,2006,23(9):1447-1450. 被引量：2
  • 3张强,郑继海,王兰君.雷莫司琼预防含顺铂化疗药物胃肠道反应80例[J].中国药师,2007,10(10):1024-1025. 被引量：2
  • 4Park HR, Ju EJ, Jo SK, et al. Enhanced antitumor efficacy of cispla- tin in combination with HemoHIM in tumor-bearing mice [J]. BMC cancer, 2009, 9(1) : 85-95.
  • 5Bosch ME, Sanchez AJ, Rojas FS, et al. Analytical methodologies for the determination of cisplatin [ J ]. J Pharmaceut Biomed Anal, 2008, 47(3) : 451-459.
  • 6Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecu- lax level (Review) [J]. Oncol Rep, 2003, 10(6) : 1663-1682.
  • 7Arany I, Safirstein RL. Cisplatin nephrotoxicity[ J]. Semin Nephrol, 2003, 23(5) : 460-464.
  • 8All BH, A1 Moundhri MS. Agents ameliorating or augmenting the nephrotoxieity of eisplatin and other platinum compounds : a review of some recent research[J]. Food Chem Toxicol, 2006, 44(8) : 1173- 1183.
  • 9Christova TY, Gorneva GA, Taxirov SI, et al. Effect of cisplatin arid cobalt chloride on antioxidani enzymes in the livers of Lewis lung carci- noma-bearing mice: protective role of heme oxygenase [ J ]. Toxicol Left, 2003, 138(3) : 235-242.
  • 10Bhattacharyya S, Mehta P. The hepatoproteetive potential of Spirulina and vitamin C supplemention in eisplatin toxicity [ J ]. Food Funct, 2012, 3(2) : 164-169.

引证文献2

二级引证文献10

中国临床康复
2004年 第29期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部